Mechanisms of HBV-Induced Innate Immunity

NIH RePORTER · NIH · R01 · $387,500 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract Chronic Hepatitis B virus infections affect about 350 million people worldwide and constitute a significant risk factor for fibrosis and hepatocellular carcinoma (HCC). HBV alters mitochondrial dynamics. HBV has been shown to induce autophagy of mitochondria (Mitophagy) as evidenced by Parkin translocation to mitochondria. We propose to investigate a possible link between mitochondrial dynamics induced by HBV and innate immunity. HBV cripples host innate immunity to maintain chronic persistent infection. Here, we propose to investigate the molecular mechanisms of HBV- induced suppression of innate immune signaling from mitochondrial platform. The key player in this process is a mitochondrial antiviral signaling protein (MAVS). There is sufficient supporting information, which shows that Parkin, an E3 ubiquitin ligase, interacts with MAVS on the mitochondria and that Parkin causes the ubiquitination of MAVS. These investigations will elucidate how MAVS is targeted by Parkin in a supracomplex and affects downstream antiviral signaling of interferon synthesis. These interactions and ubiquitinations eventually cripple innate immunity. These studies will provide unique insights into molecular mechanisms of HBV-induced mitochondrial dynamics and its effects on altering host innate immune response and open new avenues of investigations in the elucidation of innate immune pathways.

Key facts

NIH application ID
10159072
Project number
5R01AI125350-05
Recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Principal Investigator
ALEEM SIDDIQUI
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$387,500
Award type
5
Project period
2017-06-23 → 2022-05-31